John Waller

Senior director, Real World Evidence
Novo Nordisk
Zurich, Zurich, Switzerland

Presentation(s):

• PB1292 - Rationale and Design of pathfinderReal: A Prospective, Non-Interventional Study Assessing Joint Health in Adults With Haemophilia A After Switching to Prophylaxis With Turoctocog Alpha Pegol (N8-GP)

  Tuesday, June 27, 2023
  18:30 – 19:30 ET